Kaplan-Meier graphs for breast cancer incidence in the tamoxifen

CCNA2 Is a Prognostic Biomarker for ER+ Breast Cancer and Tamoxifen Resistance

Ivana SESTAK, Associate Professor in Medical Statistics

Kaplan-Meier curves for (A) event-free survival (recurrence, new tumor

Kaplan-Meier graphs for the disease-free and overall survival rates of

Extended Adjuvant Treatment with Letrozole Results in Longer

Tamoxifen with or without Breast Irradiation in Women 50 Years of Age or Older with Early Breast Cancer

Ivana SESTAK, Associate Professor in Medical Statistics

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial - The Lancet Oncology

JCM, Free Full-Text

PDF) Tamoxifen related side effects and their impact on breast

PDF) Tamoxifen related side effects and their impact on breast

The Clinical Impact of the Women's Health Initiative (WHI): Entering a New Era in Managing Postmenopausal Health Issues

Frontiers High Expression of RECQL Protein in ER-Positive Breast Tumours Is Associated With a Better Survival